Clinical Trial Vanguard

Clinical Trial Vanguard

Welcome to Clinical Trial Vanguard, your go-to platform for comprehensive insights, the latest news, and detailed analysis in the field of clinical trials.

International
English
Online/Digital

Outlet metrics

Domain Authority
37
Ranking

Global

#2179038

United States

#1205930

Category

N/A

Traffic sources
Monthly visitors

Articles

  • Revolutionizing Oncology Trials in India Through Digital Innovation

    3 days ago | clinicaltrialvanguard.com | Moe Alsumidaie

    In this interview with Dr. Seema Rajsingh, Executive Medical Director and Jarem Edwards, Clinical Scientist – Early Drug Development of Pi Health, a health technology and clinical research company transforming global access to innovative medicines and clinical trials through its proprietary AI-powered technology platform, we explore the challenges and opportunities in India’s oncology trial landscape. Despite housing 20% of the global population, India conducts only 2% of global oncology trials.

  • Behavioral Science: The Untapped Asset in Obesity Trial Strategy

    5 days ago | clinicaltrialvanguard.com | Moe Alsumidaie

    The global obesity epidemic has shifted from a public health issue to a fiercely competitive pharmaceutical frontier. With GLP-1 drugs like semaglutide and tirzepatide revolutionizing treatment and generating unprecedented commercial interest, analysts project the obesity drug market will surpass $200 billion in annual value by 2031.

  • Elevating Clinical Trial Imaging to a First-Class Data Role

    1 week ago | clinicaltrialvanguard.com | Moe Alsumidaie

    In this conversation with Jeffrey Sorenson, CEO at Yunu, we explore the transformative potential of treating imaging data as a first-class citizen in clinical trials. Sorenson, who spearheads innovative imaging solutions, discusses the necessary structural shifts in clinical trial protocols, the integration of advanced data systems, and the future of imaging in oncology studies.

  • FDA Dropped Diversity But Good Science Depends On It

    2 weeks ago | clinicaltrialvanguard.com | Moe Alsumidaie

    In this conversation, Thad Wolfram, Chief Strategy Officer of EmVenio Research and PCM Trials, shares his insights on the critical importance of inclusivity in clinical research, the impact of regulatory changes, and the role of community-based research in advancing medical science. Research should factor race, age, sex at birth, socioeconomic and demographic diversity.

  • Scaling GenAI in Life Sciences: Overcoming Barriers with Strategy, Compliance, and Human Insight

    2 weeks ago | clinicaltrialvanguard.com | Moe Alsumidaie

    As GenAI gains traction across life sciences, the conversation is rapidly shifting from potential to practicality. Yet, many organizations remain stuck in pilot purgatory, unable to scale solutions enterprise-wide. In this interview, Ram Yeleswarapu, SVP of Enterprise Clinical Solutions at Indegene, shares hard-earned insights from deploying GenAI across over 70 use cases in clinical and medical domains.

Contact details

Address

123 Example Street

City, Country 12345

Email

[email protected]

Website

http://clinicaltrialvanguard.com

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations